| Dataset | DGIdb Drug Targets 2026 |
| Category | physical interactions |
| Type | drug |
| Description | (3R,5S)-3,5-dihydroxyhept-6-enoic acid in which the (7E)-hydrogen is substituted by a 4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl group. Formerly used (as its sodium salt) to lower cholesterol and prevent cardiovascular disease, it was withdrawn from the market worldwide in 2001 following reports of a severe form of muscle toxicity. (Chemical Entities of Biological Interest Ontology, CHEBI_3558) |
| External Link | https://dgidb.org/results?searchType=drug&searchTerms=CERIVASTATIN |
| Similar Terms | |
| Downloads & Tools |
4 interacting proteins for the CERIVASTATIN drug from theDGIdb Drug Targets 2026 dataset.
